Crossmark

Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students—which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?

Crossref DOI link: https://doi.org/10.1186/s40902-021-00330-6

Published Online: 2022-01-13

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Houshmand, Behzad

Keyhan, Seied Omid

Fallahi, Hamid Reza

Ramezanzade, Shaqayeq http://orcid.org/0000-0002-1012-0730
Sadeghi, Erfan

Yousefi, Parisa
License Information

Text and Data Mining valid from 2022-01-13

Version of Record valid from 2022-01-13
More Information

Article History

Received: 16 July 2021

Accepted: 27 August 2021

First Online: 13 January 2022

Declarations

:

: This study followed the American Association for Public Opinion Research (AAPOR) reporting guideline (Pitt et al. 2021), and the study protocol was registered at Shahid Beheshti University of Medical Sciences, with registration number IR.SBMU. RETECH. REC. 1400.164.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below